H.C. Wainwright Reiterates Buy Rating on Akari Therapeutics (AKTX)

Go back to H.C. Wainwright Reiterates Buy Rating on Akari Therapeutics (AKTX)
(NASDAQ: AKTX) Delayed: 7.18 -0.55 (7.12%)
Previous Close $7.73    52 Week High $19.75 
Open $7.58    52 Week Low $7.63 
Day High $7.60    P/E N/A 
Day Low $7.00    EPS $0.00 
Volume 56,336